Histological sections of Th2-stimulated reconstructed human epidermis (RHE) after 48 h or topical and systemic treatments with the test compounds and reference of its solvent, respectively (H/E staining; n = 1). (a) control; (b) Th2 (+PBS topic); (c) Th2 + DMSO 0.05% (d) Th2 + 10 µM GW3965 in 0.05% DMSO; (e) Th2 + 100 µ/mL FV; (f) Th2 + 100 µ/mL UP.
Atopic dermatitis is a multifactorial pathology that includes perturbations of gene expression and increased adhesion of Staphylococcus aureus. Fucoidans are seaweed-derived sulfated fucose-rich polysaccharides that are known to be anti-inflammatory and may inhibit adhesion of pathogens. Fucoidan was assessed for effects on gene expression of an in vitro 3D model of atopic dermatitis. It was also assessed for inhibitory effects on the adhesion of bacteria onto 3D reconstructed skin. Fucoidan significantly altered gene expression in the atopic dermatitis model, and there was a trend to reduce periostin levels. Fucoidan significantly inhibited the adhesion of Staphylococcus aureus and Cutibacterium acnes but did not affect the adhesion of Staphylococcus epidermidis. Fucoidan may be a useful topical agent to assist in the management of atopic dermatitis.
READ THE FULL ARTICLE: https://www.mdpi.com/2296-3529/8/2/12